<DOC>
	<DOC>NCT02170740</DOC>
	<brief_summary>To assess safety, pharmacokinetics and the effect of BIBR 1048 MS on coagulation parameters in healthy volunteer subjects.</brief_summary>
	<brief_title>Assessment of Safety, Pharmacokinetics and the Effect of BIBR 1048 MS on Coagulation Parameters in Healthy Volunteer Subjects</brief_title>
	<detailed_description />
	<mesh_term>Pantoprazole</mesh_term>
	<mesh_term>Dabigatran</mesh_term>
	<criteria>Healthy male subjects as determined by results of screening Signed written informed consent in accordance with GCP and local legislation Age ≥ 18 and ≤ 50 years Broca ≥ 20% and ≤ + 20% Any finding of the medical examination (including blood pressure, pulse rate and electrocardiogram (ECG)) deviating from normal and of clinical relevance History or current gastrointestinal, hepatic, renal, respiratory, cardiovascular, metabolic, immunologic, hormonal disorders History of orthostatic hypotension, fainting spells and blackouts Diseases of the central nervous system (such as epilepsy) or psychiatric disorders Chronic or relevant acute infections History of allergy/hypersensitivity (including drug allergy) which is deemed relevant to the trial as judged by the investigator History of any bleeding disorder including prolonged or habitual bleeding History of other hematologic disease History of cerebral bleeding (e.g. after a car accident) History of commotio cerebri Intake of drugs with a longlife (&gt; 24 hours) within 1 month prior to administration Use of any drug which might influence the results of the trial within 10 days prior to administration or during the trial Participation in another trial with investigational drug within 2 months prior to administration or during the trial Smoker (&gt; 10 cigarettes or 3 cigars or 3 pipes/day) or inability to refrain from smoking on study days Alcohol abuse (&gt; 60g/day) Drug abuse Blood donation within 1 month prior to administration or during the trial Excessive physical activities within 5 days prior to administration or during the trial Any laboratory value outside the clinically accepted reference range History of any familiar bleeding disorder Thrombocytes &lt; 150000/µl</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>